Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

By sjmartinez • February 2, 2024

Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, Kristensen LE, Ytterberg SR, Hamar A, Fleischmann R. Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol. 2024 Feb 1. doi: 10.1038/s41584-024-01085-w. Epub ahead of print. Erratum for: Nat Rev Rheumatol. 2024 Feb;20(2):101-115. PMID: 38302658.

Tags: Publications, Rheumatology

Genetic Research within Indigenous Communities: Engagement Opportunities and Pathways Forward

Barton KS, Porter KM, Mai T, Claw KG, Hiratsuka VY, Carroll SR, Burke W, Garrison NA. Genetic Research within Indigenous Communities: Engagement Opportunities and Pathways[...]

Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study

Rastogi A, Pollack CV Jr, Sánchez Lázaro IJ, Lesén E, Arnold M, Franzén S, Allum A, Hernández I, Murohara T, Kanda E. Maintained renin-angiotensin-aldosterone system[...]

A Tale of Two Islands – Leptospirosis in Strikingly Different Ecological Settings Reveals Pathogenomic Insights

Haake DA. A Tale of Two Islands - Leptospirosis in Strikingly Different Ecological Settings Reveals Pathogenomic Insights. Am J Trop Med Hyg. 2024 May 2:tpmd240254.[...]